{
"info": {
"nct_id": "NCT00178373",
"official_title": "Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer",
"inclusion_criteria": "* Patient is longer than one-month post chemotherapy and/or radiation treatment for an initial diagnosis of cancer\n* Patient is 18 years of age or older\n* Patient is able to swallow medication\n* Patient has a Brief Fatigue Inventory (BFI) question #3 \"fatigue worst\" score of 2 or greater\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patient has ever taken modafinil (PROVIGIL)\n* Patient has taken an anticonvulsant for a seizure disorder; has taken any of the following on a regular basis within the past 30 days, a psychostimulant (e.g., amphetamines, methylphenidate [Ritalin], pemoline [Cylert]), or a monoamine oxidase inhibitor (MAOIs)\n* Patient has a history of clinically significant cardiac disease, uncontrolled hypertension, alcohol or drug abuse, severe headaches, glaucoma, seizure disorder, narcolepsy, a psychotic disorder, or Tourette's syndrome\n* Patient presently taking on a regular basis:\n\n * an anticoagulant (Coumadin [warfarin], heparin); note that low dose Coumadin (1 mg by mouth daily) given for maintenance of venous access devices is acceptable\n * alpha-interferon or interleukin-2,\n * a corticosteroid (dexamethasone, prednisone, prednisolone)\n* Patient has a narrowing (pathological or iatrogenic) or obstruction of the gastrointestinal tract\n* Patient is currently pregnant or nursing (if currently using a steroidal contraceptive for fertility control, participant must agree to use a barrier method of contraception during the study and for one full menstrual cycle following the study\n* Patient has uncontrolled anemia; receiving treatment for anemia and currently stable is acceptable",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patient is longer than one-month post chemotherapy and/or radiation treatment for an initial diagnosis of cancer",
"criterions": [
{
"exact_snippets": "longer than one-month post chemotherapy",
"criterion": "post chemotherapy duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
},
{
"exact_snippets": "longer than one-month post ... radiation treatment",
"criterion": "post radiation treatment duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
},
{
"exact_snippets": "initial diagnosis of cancer",
"criterion": "initial diagnosis of cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient is 18 years of age or older",
"criterions": [
{
"exact_snippets": "18 years of age or older",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Patient is able to swallow medication",
"criterions": [
{
"exact_snippets": "able to swallow medication",
"criterion": "ability to swallow medication",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has a Brief Fatigue Inventory (BFI) question #3 \"fatigue worst\" score of 2 or greater",
"criterions": [
{
"exact_snippets": "Brief Fatigue Inventory (BFI) question #3 \"fatigue worst\" score of 2 or greater",
"criterion": "fatigue worst score",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "healthy volunteers",
"requirements": [
{
"requirement_type": "participation",
"expected_value": true
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patient has ever taken modafinil (PROVIGIL)",
"criterions": [
{
"exact_snippets": "Patient has ever taken modafinil (PROVIGIL)",
"criterion": "modafinil (PROVIGIL) usage",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has taken an anticonvulsant for a seizure disorder; has taken any of the following on a regular basis within the past 30 days, a psychostimulant (e.g., amphetamines, methylphenidate [Ritalin], pemoline [Cylert]), or a monoamine oxidase inhibitor (MAOIs)",
"criterions": [
{
"exact_snippets": "Patient has taken an anticonvulsant for a seizure disorder",
"criterion": "anticonvulsant use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "has taken any of the following on a regular basis within the past 30 days, a psychostimulant (e.g., amphetamines, methylphenidate [Ritalin], pemoline [Cylert])",
"criterion": "psychostimulant use",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within the past 30 days"
}
]
},
{
"exact_snippets": "has taken any of the following on a regular basis within the past 30 days, ... a monoamine oxidase inhibitor (MAOIs)",
"criterion": "monoamine oxidase inhibitor use",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within the past 30 days"
}
]
}
]
},
{
"line": "* Patient has a history of clinically significant cardiac disease, uncontrolled hypertension, alcohol or drug abuse, severe headaches, glaucoma, seizure disorder, narcolepsy, a psychotic disorder, or Tourette's syndrome",
"criterions": [
{
"exact_snippets": "history of clinically significant cardiac disease",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "clinical significance",
"expected_value": true
}
]
},
{
"exact_snippets": "uncontrolled hypertension",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "alcohol or drug abuse",
"criterion": "substance abuse",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "severe headaches",
"criterion": "headaches",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
},
{
"exact_snippets": "glaucoma",
"criterion": "glaucoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "seizure disorder",
"criterion": "seizure disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "narcolepsy",
"criterion": "narcolepsy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "psychotic disorder",
"criterion": "psychotic disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Tourette's syndrome",
"criterion": "Tourette's syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient presently taking on a regular basis:",
"criterions": [
{
"exact_snippets": "Patient presently taking on a regular basis",
"criterion": "medication usage",
"requirements": [
{
"requirement_type": "frequency",
"expected_value": "regular"
}
]
}
]
},
{
"line": "* an anticoagulant (Coumadin [warfarin], heparin); note that low dose Coumadin (1 mg by mouth daily) given for maintenance of venous access devices is acceptable",
"criterions": [
{
"exact_snippets": "an anticoagulant (Coumadin [warfarin], heparin)",
"criterion": "anticoagulant use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "low dose Coumadin (1 mg by mouth daily) given for maintenance of venous access devices is acceptable",
"criterion": "low dose Coumadin for venous access devices",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* alpha-interferon or interleukin-2,",
"criterions": [
{
"exact_snippets": "alpha-interferon",
"criterion": "alpha-interferon",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "interleukin-2",
"criterion": "interleukin-2",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* a corticosteroid (dexamethasone, prednisone, prednisolone)",
"criterions": [
{
"exact_snippets": "a corticosteroid (dexamethasone, prednisone, prednisolone)",
"criterion": "corticosteroid",
"requirements": [
{
"requirement_type": "types",
"expected_value": [
"dexamethasone",
"prednisone",
"prednisolone"
]
}
]
}
]
},
{
"line": "* Patient has a narrowing (pathological or iatrogenic) or obstruction of the gastrointestinal tract",
"criterions": [
{
"exact_snippets": "narrowing (pathological or iatrogenic) ... of the gastrointestinal tract",
"criterion": "narrowing of the gastrointestinal tract",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "obstruction of the gastrointestinal tract",
"criterion": "obstruction of the gastrointestinal tract",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has uncontrolled anemia; receiving treatment for anemia and currently stable is acceptable",
"criterions": [
{
"exact_snippets": "Patient has uncontrolled anemia",
"criterion": "anemia",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "receiving treatment for anemia and currently stable is acceptable",
"criterion": "anemia treatment",
"requirements": [
{
"requirement_type": "stability",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Patient is currently pregnant or nursing (if currently using a steroidal contraceptive for fertility control, participant must agree to use a barrier method of contraception during the study and for one full menstrual cycle following the study",
"criterions": [
{
"exact_snippets": "Patient is currently pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "currently nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "currently using a steroidal contraceptive for fertility control",
"criterion": "steroidal contraceptive use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "participant must agree to use a barrier method of contraception during the study and for one full menstrual cycle following the study",
"criterion": "barrier method of contraception",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
}
]
}
],
"failed_miscellaneous": []
}